Helus Pharma Slides 1.5% as Market Signals Bear on Psychedelic Pipeline
Helus Pharma (HELP) drops 1.5% amid mixed signals—despite a 21% monthly decline, investors watch for breakthrough therapeutics and strategic moves.
2 minutes to read
HELUS PHARMA INC
Helus Pharma (HELP) Q3 Update: Stock Slips 1.46%, Corporate Filing Confirms Compliance
Helus Pharma (HELP) trades near $11 with a 21% YTD decline. Despite modest filings, its psychedelic drug pipeline and market cap of $770 M signal steady, compliant growth.
2 minutes to read
Helus Pharma (HELP) Climbs 2.34% to $10.77 Amid Market‑Wide Decline, Outpacing Peers
Helus Pharma (HELP) stock rises 2.34% to $10.77, outperforming peers with a 19.91% monthly drop; discover its psychedelic therapy focus and market dynamics.
2 minutes to read